is glp-1 bad for you GLP-1 | Summary

Cosmevias Fanny Coste shares the strategies that brands and suppliers are using to address the impact of rapid weight loss from GLP-1 drugs on facial skin

From Trend to Research Topic You mayRead Article

Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node GLP-1 has direct chronotropic effects on the heart mediated by GLP-1 receptors in pacemaker cells of the sinus node, inducing changes in action potential morphology

Bottom line: GLP-1s opened the door by proving obesity therapies can be CV disease interventions

This Canadian development could have broader implications across North America, potentially influencing how metabolic health treatments are delivered and priced in the future

One of the largest US health insurers is ending coverage of GLP-1 weight-loss drugs for its employees but will continue covering them for people with type 2 diabetes.